Firebrick Pharma Ltd
ASX:FRE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Firebrick Pharma Ltd
ASX:FRE
|
AU |
|
SJVN Ltd
NSE:SJVN
|
IN |
|
Busan Industrial Co Ltd
KRX:011390
|
KR |
|
Kitex Garments Ltd
NSE:KITEX
|
IN |
|
H
|
Hanjin Heavy Ind & Const Holdings Co Ltd
KRX:003480
|
KR |
|
L
|
Landa App LLC
OTC:LBVDS
|
US |
|
R
|
Rubicon Water Ltd
ASX:RWL
|
AU |
|
Saudi Telecom Company SJSC
SAU:7010
|
SA |
|
ICICI Securities Ltd
NSE:ISEC
|
IN |
|
ICP Ltd
SGX:5I4
|
SG |
|
N
|
Nanjing Quanxin Cable Technology Co Ltd
SZSE:300447
|
CN |
|
A
|
Allied Blenders and Distillers Ltd
NSE:ABDL
|
IN |
|
P
|
Purmo Group Oyj
OMXH:PURMO
|
FI |
|
LG Electronics Inc
KRX:066570
|
KR |
|
S
|
Solid World Group SpA
F:F17
|
IT |
|
K
|
Kone Oyj
OMXH:KNEBV
|
FI |
|
Winton Land Ltd
NZX:WIN
|
NZ |
|
Keyware Technologies NV
XBRU:KEYW
|
BE |
|
P
|
Parker-Hannifin Corp
LSE:0KFZ
|
US |
|
Silk Logistics Holdings Ltd
ASX:SLH
|
AU |
|
Canadian General Medical Centers Complex Company CJSC
SAU:9518
|
SA |
|
P
|
Przedsiebiorstwo Produkcyjno Handlowe Kompap SA
WSE:KMP
|
PL |
|
A
|
Altri SGPS SA
ELI:ALTR
|
PT |
|
Takuma Co Ltd
TSE:6013
|
JP |
Firebrick Pharma Ltd
Firebrick Pharma Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-28. The firm is focused to develop Nasodine, a nasal spray that contains the broad spectrum antimicrobial agent called povidone-iodine. The firm is engaged in product formulation, packaging and manufacturing development. Nasodine nasal spray medicine targets the cause of colds, where they start in the nose. Its nasal spray is responsible for respiratory infections, such as the common cold. The firm's Series C funding, Phase III trial has been completed.
Firebrick Pharma Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-28. The firm is focused to develop Nasodine, a nasal spray that contains the broad spectrum antimicrobial agent called povidone-iodine. The firm is engaged in product formulation, packaging and manufacturing development. Nasodine nasal spray medicine targets the cause of colds, where they start in the nose. Its nasal spray is responsible for respiratory infections, such as the common cold. The firm's Series C funding, Phase III trial has been completed.
